Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Mar 15;97(6):1512–1524. doi: 10.1172/JCI118574

Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice.

C S Chiang 1, H C Powell 1, L H Gold 1, A Samimi 1, I L Campbell 1
PMCID: PMC507212  PMID: 8617885

Abstract

Activated macrophage/microglia may mediate tissue injury in a variety of CNS disorders. To examine this, transgenic mice were developed in which the expression of a macrophage/microglia activation cytokine, interleukin-3 (IL-3), was targeted to astrocytes using a murine glial fibrillary acidic protein fusion gene. Transgenic mice with low levels of IL-3 expression developed from 5 mo of age, a progressive motor disorder characterized at onset by impaired rota-rod performance. In symptomatic transgenic mice, multi-focal, plaque-like white matter lesions were present in cerebellum and brain stem. Lesions showed extensive primary demyelination and remyelination in association with the accumulation of large numbers of proliferating and activated foamy macrophage/microglial cells. Many of these cells also contained intracisternal crystalline pole-like inclusions similar to those seen in human patients with multiple sclerosis. Mast cells were also identified while lymphocytes were rarely, if at all present. Thus, chronic CNS production of low levels of IL-3 promotes the recruitment, proliferation and activation of macrophage/microglial cells in white matter regions with consequent primary demyelination and motor disease. This transgenic model exhibits many of the features of human inflammatory demyelinating diseases including multiple sclerosis and HIV leukoencephalopathy.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams C. W., Poston R. N., Buk S. J. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci. 1989 Sep;92(2-3):291–306. doi: 10.1016/0022-510x(89)90144-5. [DOI] [PubMed] [Google Scholar]
  2. Aglietta M., Sanavio F., Stacchini A., Morelli S., Fubini L., Severino A., Pasquino P., Volta C., Bretti S., Tafuto S. Interleukin-3 in vivo: kinetic of response of target cells. Blood. 1993 Oct 1;82(7):2054–2061. [PubMed] [Google Scholar]
  3. Andersson P. B., Perry V. H., Gordon S. Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system. J Exp Med. 1992 Jul 1;176(1):255–259. doi: 10.1084/jem.176.1.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Andersson P. B., Perry V. H., Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience. 1992;48(1):169–186. doi: 10.1016/0306-4522(92)90347-5. [DOI] [PubMed] [Google Scholar]
  5. Appel K., Buttini M., Sauter A., Gebicke-Haerter P. J. Cloning of rat interleukin-3 receptor beta-subunit from cultured microglia and its mRNA expression in vivo. J Neurosci. 1995 Aug;15(8):5800–5809. doi: 10.1523/JNEUROSCI.15-08-05800.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Araujo D. M., Lapchak P. A. Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's diseases: selective effects on specific interleukins and interleukin receptors. Neuroscience. 1994 Aug;61(4):745–754. doi: 10.1016/0306-4522(94)90398-0. [DOI] [PubMed] [Google Scholar]
  7. Badley J. E., Bishop G. A., St John T., Frelinger J. A. A simple, rapid method for the purification of poly A+ RNA. Biotechniques. 1988 Feb;6(2):114–116. [PubMed] [Google Scholar]
  8. Banati R. B., Gehrmann J., Schubert P., Kreutzberg G. W. Cytotoxicity of microglia. Glia. 1993 Jan;7(1):111–118. doi: 10.1002/glia.440070117. [DOI] [PubMed] [Google Scholar]
  9. Benoist C. O., Mathis D. J., Kanter M. R., Williams V. E., 2nd, McDevitt H. O. Regions of allelic hypervariability in the murine A alpha immune response gene. Cell. 1983 Aug;34(1):169–177. doi: 10.1016/0092-8674(83)90147-2. [DOI] [PubMed] [Google Scholar]
  10. Bird T. D., Farrell D. F., Sumi S. M. Brain lipid composition of the shiverer mouse: (genetic defect in myelin development). J Neurochem. 1978 Jul;31(1):387–391. doi: 10.1111/j.1471-4159.1978.tb12479.x. [DOI] [PubMed] [Google Scholar]
  11. Boyle E. A., McGeer P. L. Cellular immune response in multiple sclerosis plaques. Am J Pathol. 1990 Sep;137(3):575–584. [PMC free article] [PubMed] [Google Scholar]
  12. Brosnan C. F., Bornstein M. B., Bloom B. R. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol. 1981 Feb;126(2):614–620. [PubMed] [Google Scholar]
  13. Brück W., Friede R. L. Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro. Acta Neuropathol. 1990;80(4):415–418. doi: 10.1007/BF00307696. [DOI] [PubMed] [Google Scholar]
  14. Campbell I. L., Abraham C. R., Masliah E., Kemper P., Inglis J. D., Oldstone M. B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10061–10065. doi: 10.1073/pnas.90.21.10061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Campbell I. L., Hobbs M. V., Kemper P., Oldstone M. B. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J Immunol. 1994 Jan 15;152(2):716–723. [PubMed] [Google Scholar]
  16. Chiang C. S., McBride W. H. Radiation enhances tumor necrosis factor alpha production by murine brain cells. Brain Res. 1991 Dec 6;566(1-2):265–269. doi: 10.1016/0006-8993(91)91707-8. [DOI] [PubMed] [Google Scholar]
  17. Chiang C. S., McBride W. H., Withers H. R. Radiation-induced astrocytic and microglial responses in mouse brain. Radiother Oncol. 1993 Oct;29(1):60–68. doi: 10.1016/0167-8140(93)90174-7. [DOI] [PubMed] [Google Scholar]
  18. Chiang C. S., Stalder A., Samimi A., Campbell I. L. Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev Neurosci. 1994;16(3-4):212–221. doi: 10.1159/000112109. [DOI] [PubMed] [Google Scholar]
  19. Colton C. A., Gilbert D. L. Microglia, an in vivo source of reactive oxygen species in the brain. Adv Neurol. 1993;59:321–326. [PubMed] [Google Scholar]
  20. DUNHAM N. W., MIYA T. S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc. 1957 Mar;46(3):208–209. doi: 10.1002/jps.3030460322. [DOI] [PubMed] [Google Scholar]
  21. Davis E. J., Foster T. D., Thomas W. E. Cellular forms and functions of brain microglia. Brain Res Bull. 1994;34(1):73–78. doi: 10.1016/0361-9230(94)90189-9. [DOI] [PubMed] [Google Scholar]
  22. Dickson D. W., Mattiace L. A., Kure K., Hutchins K., Lyman W. D., Brosnan C. F. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest. 1991 Feb;64(2):135–156. [PubMed] [Google Scholar]
  23. Ffrench-Constant C. Pathogenesis of multiple sclerosis. Lancet. 1994 Jan 29;343(8892):271–275. doi: 10.1016/s0140-6736(94)91118-5. [DOI] [PubMed] [Google Scholar]
  24. Frendl G., Beller D. I. Regulation of macrophage activation by IL-3. I. IL-3 functions as a macrophage-activating factor with unique properties, inducing Ia and lymphocyte function-associated antigen-1 but not cytotoxicity. J Immunol. 1990 May 1;144(9):3392–3399. [PubMed] [Google Scholar]
  25. Frendl G. Interleukin 3: from colony-stimulating factor to pluripotent immunoregulatory cytokine. Int J Immunopharmacol. 1992 Apr;14(3):421–430. doi: 10.1016/0192-0561(92)90172-h. [DOI] [PubMed] [Google Scholar]
  26. Friede R. L., Brück W. Macrophage functional properties during myelin degradation. Adv Neurol. 1993;59:327–336. [PubMed] [Google Scholar]
  27. Gebicke-Haerter P. J., Appel K., Taylor G. D., Schobert A., Rich I. N., Northoff H., Berger M. Rat microglial interleukin-3. J Neuroimmunol. 1994 Mar;50(2):203–214. doi: 10.1016/0165-5728(94)90047-7. [DOI] [PubMed] [Google Scholar]
  28. Giulian D., Vaca K., Corpuz M. Brain glia release factors with opposing actions upon neuronal survival. J Neurosci. 1993 Jan;13(1):29–37. doi: 10.1523/JNEUROSCI.13-01-00029.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Gray F., Lescs M. C. HIV-related demyelinating disease. Eur J Med. 1993 Feb;2(2):89–96. [PubMed] [Google Scholar]
  30. Griffin J. W., Stoll G., Li C. Y., Tyor W., Cornblath D. R. Macrophage responses in inflammatory demyelinating neuropathies. Ann Neurol. 1990;27 (Suppl):S64–S68. doi: 10.1002/ana.410270717. [DOI] [PubMed] [Google Scholar]
  31. Hauser S. L., Bhan A. K., Gilles F., Kemp M., Kerr C., Weiner H. L. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol. 1986 Jun;19(6):578–587. doi: 10.1002/ana.410190610. [DOI] [PubMed] [Google Scholar]
  32. Hobbs M. V., Weigle W. O., Noonan D. J., Torbett B. E., McEvilly R. J., Koch R. J., Cardenas G. J., Ernst D. N. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J Immunol. 1993 Apr 15;150(8 Pt 1):3602–3614. [PubMed] [Google Scholar]
  33. Hulkower K., Brosnan C. F., Aquino D. A., Cammer W., Kulshrestha S., Guida M. P., Rapoport D. A., Berman J. W. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J Immunol. 1993 Mar 15;150(6):2525–2533. [PubMed] [Google Scholar]
  34. Jones B. J., Roberts D. J. The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod. J Pharm Pharmacol. 1968 Apr;20(4):302–304. doi: 10.1111/j.2042-7158.1968.tb09743.x. [DOI] [PubMed] [Google Scholar]
  35. Kurzrock R., Talpaz M., Estrov Z., Rosenblum M. G., Gutterman J. U. Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. J Clin Oncol. 1991 Jul;9(7):1241–1250. doi: 10.1200/JCO.1991.9.7.1241. [DOI] [PubMed] [Google Scholar]
  36. Laffan E. W., Lisciotto C. A., Gapp D. A., Weldon D. A. Development of rotorod performance in normal and congenitally hypothyroid mutant mice. Behav Neural Biol. 1989 Nov;52(3):411–416. doi: 10.1016/s0163-1047(89)90532-3. [DOI] [PubMed] [Google Scholar]
  37. Lampert P. W. Autoimmune and virus-induced demyelinating diseases. A review. Am J Pathol. 1978 Apr;91(1):176–208. [PMC free article] [PubMed] [Google Scholar]
  38. Lawson L. J., Perry V. H., Dri P., Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 1990;39(1):151–170. doi: 10.1016/0306-4522(90)90229-w. [DOI] [PubMed] [Google Scholar]
  39. Lee T. T., Martin F. C., Merrill J. E. Lymphokine induction of rat microglia multinucleated giant cell formation. Glia. 1993 May;8(1):51–61. doi: 10.1002/glia.440080107. [DOI] [PubMed] [Google Scholar]
  40. Li H., Newcombe J., Groome N. P., Cuzner M. L. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol Appl Neurobiol. 1993 Jun;19(3):214–223. doi: 10.1111/j.1365-2990.1993.tb00431.x. [DOI] [PubMed] [Google Scholar]
  41. Ling E. A., Wong W. C. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia. 1993 Jan;7(1):9–18. doi: 10.1002/glia.440070105. [DOI] [PubMed] [Google Scholar]
  42. Louis J. C., Magal E., Takayama S., Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science. 1993 Jan 29;259(5095):689–692. doi: 10.1126/science.8430320. [DOI] [PubMed] [Google Scholar]
  43. Martin R., McFarland H. F., McFarlin D. E. Immunological aspects of demyelinating diseases. Annu Rev Immunol. 1992;10:153–187. doi: 10.1146/annurev.iy.10.040192.001101. [DOI] [PubMed] [Google Scholar]
  44. McBride W. H., Dougherty G. D., Wallis A. E., Economou J. S., Chiang C. S. Interleukin-3 in gene therapy of cancer. Folia Biol (Praha) 1994;40(1-2):62–73. [PubMed] [Google Scholar]
  45. McGeer P. L., Itagaki S., Boyes B. E., McGeer E. G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 1988 Aug;38(8):1285–1291. doi: 10.1212/wnl.38.8.1285. [DOI] [PubMed] [Google Scholar]
  46. McGeer P. L., Kawamata T., Walker D. G., Akiyama H., Tooyama I., McGeer E. G. Microglia in degenerative neurological disease. Glia. 1993 Jan;7(1):84–92. doi: 10.1002/glia.440070114. [DOI] [PubMed] [Google Scholar]
  47. Merrill J. E., Ignarro L. J., Sherman M. P., Melinek J., Lane T. E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol. 1993 Aug 15;151(4):2132–2141. [PubMed] [Google Scholar]
  48. Mikoshiba K., Nagaike K., Tsukada Y. Subcellular distribution and developmental change of 2',3'-cyclic nucleotide 3'-phosphohydrolase in the central nervous system of the myelin-deficient shiverer mutant mice. J Neurochem. 1980 Aug;35(2):465–470. doi: 10.1111/j.1471-4159.1980.tb06288.x. [DOI] [PubMed] [Google Scholar]
  49. Mucke L., Oldstone M. B., Morris J. C., Nerenberg M. I. Rapid activation of astrocyte-specific expression of GFAP-lacZ transgene by focal injury. New Biol. 1991 May;3(5):465–474. [PubMed] [Google Scholar]
  50. Nakajima K., Kohsaka S. Functional roles of microglia in the brain. Neurosci Res. 1993 Aug;17(3):187–203. doi: 10.1016/0168-0102(93)90047-t. [DOI] [PubMed] [Google Scholar]
  51. Nelson L. M., Franklin G. M., Jones M. C. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA. 1988 Jun 17;259(23):3441–3443. [PubMed] [Google Scholar]
  52. Nesbit G. M., Forbes G. S., Scheithauer B. W., Okazaki H., Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology. 1991 Aug;180(2):467–474. doi: 10.1148/radiology.180.2.2068314. [DOI] [PubMed] [Google Scholar]
  53. Newcombe J., Li H., Cuzner M. L. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol. 1994 Apr;20(2):152–162. doi: 10.1111/j.1365-2990.1994.tb01174.x. [DOI] [PubMed] [Google Scholar]
  54. Oster W., Frisch J., Nicolay U., Schulz G. Interleukin-3. Biologic effects and clinical impact. Cancer. 1991 May 15;67(10 Suppl):2712–2717. doi: 10.1002/1097-0142(19910515)67:10+<2712::aid-cncr2820671708>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  55. Pellegrino L. J., Altman J. Effects of differential interference with postnatal cerebellar neurogenesis on motor performance, activity level, and maze learning of rats: a developmental study. J Comp Physiol Psychol. 1979 Feb;93(1):1–33. doi: 10.1037/h0077589. [DOI] [PubMed] [Google Scholar]
  56. Powell H. C., Myers R. R., Mizisin A. P., Olee T., Brostoff S. W. Response of the axon and barrier endothelium to experimental allergic neuritis induced by autoreactive T cell lines. Acta Neuropathol. 1991;82(5):364–377. doi: 10.1007/BF00296547. [DOI] [PubMed] [Google Scholar]
  57. Prineas J. W., Barnard R. O., Kwon E. E., Sharer L. R., Cho E. S. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol. 1993 Feb;33(2):137–151. doi: 10.1002/ana.410330203. [DOI] [PubMed] [Google Scholar]
  58. Prineas J. W., Barnard R. O., Revesz T., Kwon E. E., Sharer L., Cho E. S. Multiple sclerosis. Pathology of recurrent lesions. Brain. 1993 Jun;116(Pt 3):681–693. doi: 10.1093/brain/116.3.681. [DOI] [PubMed] [Google Scholar]
  59. Prohaska J. R., Clark D. A., Wells W. W. Improved rapidity and precision in the determination of brain 2',3'-cyclic nucleotide 3'-phosphohydrolase. Anal Biochem. 1973 Nov;56(1):275–282. doi: 10.1016/0003-2697(73)90189-9. [DOI] [PubMed] [Google Scholar]
  60. Pulaski B. A., McAdam A. J., Hutter E. K., Biggar S., Lord E. M., Frelinger J. G. Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. Cancer Res. 1993 May 1;53(9):2112–2117. [PubMed] [Google Scholar]
  61. Raine C. S., Wu E. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol. 1993 May;52(3):199–204. [PubMed] [Google Scholar]
  62. Reyes A. A., Schöld M., Wallace R. B. The complete amino acid sequence of the murine transplantation antigen H-2Db as deduced by molecular cloning. Immunogenetics. 1982;16(1):1–9. doi: 10.1007/BF00364437. [DOI] [PubMed] [Google Scholar]
  63. Rodriguez M., Scheithauer B. Ultrastructure of multiple sclerosis. Ultrastruct Pathol. 1994 Jan-Apr;18(1-2):3–13. doi: 10.3109/01913129409016267. [DOI] [PubMed] [Google Scholar]
  64. Schrader J. W. The panspecific hemopoietin of activated T lymphocytes (interleukin-3). Annu Rev Immunol. 1986;4:205–230. doi: 10.1146/annurev.iy.04.040186.001225. [DOI] [PubMed] [Google Scholar]
  65. Selmaj K., Raine C. S., Farooq M., Norton W. T., Brosnan C. F. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol. 1991 Sep 1;147(5):1522–1529. [PubMed] [Google Scholar]
  66. Smith T. W., DeGirolami U., Hénin D., Bolgert F., Hauw J. J. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol. 1990 Jul;49(4):357–370. doi: 10.1097/00005072-199007000-00001. [DOI] [PubMed] [Google Scholar]
  67. Thach W. T., Goodkin H. P., Keating J. G. The cerebellum and the adaptive coordination of movement. Annu Rev Neurosci. 1992;15:403–442. doi: 10.1146/annurev.ne.15.030192.002155. [DOI] [PubMed] [Google Scholar]
  68. Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham C. R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 1994 Jan 13;367(6459):188–193. doi: 10.1038/367188a0. [DOI] [PubMed] [Google Scholar]
  69. Tokunaga K., Taniguchi H., Yoda K., Shimizu M., Sakiyama S. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. Nucleic Acids Res. 1986 Mar 25;14(6):2829–2829. doi: 10.1093/nar/14.6.2829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Toms R., Weiner H. L., Johnson D. Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J Neuroimmunol. 1990 Dec;30(2-3):169–177. doi: 10.1016/0165-5728(90)90101-r. [DOI] [PubMed] [Google Scholar]
  71. Williams K., Ulvestad E., Waage A., Antel J. P., McLaurin J. Activation of adult human derived microglia by myelin phagocytosis in vitro. J Neurosci Res. 1994 Jul 1;38(4):433–443. doi: 10.1002/jnr.490380409. [DOI] [PubMed] [Google Scholar]
  72. Zhao M. L., Xia J. Q., Fritz R. B. Interleukin-3 and encephalitogenic activity of SJL/J myelin basic protein-specific T cell lines. J Neuroimmunol. 1993 Mar;43(1-2):69–78. doi: 10.1016/0165-5728(93)90076-b. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES